Pathophysiology of protein-energy wasting in chronic renal failure

被引:120
作者
Kopple, JD
机构
[1] Harbor UCLA Res & Educ Inst Inc, Div Nephrol & Hypertens, Torrance, CA 90502 USA
[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA
关键词
renal failure; hemodialysis; peritoneal dialysis; malnutrition; protein-energy malnutrition;
D O I
10.1093/jn/129.1.247S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
There is a high prevalence of protein-energy malnutrition in both nondialyzed patients with advanced chronic renal failure and in those individuals with end-stage renal disease who are receiving maintenance hemodialysis or chronic peritoneal dialysis therapy. Approximately one-third of maintenance dialysis patients have mild to moderate protein-energy malnutrition, and about 6 to 8 percent of these individuals have severe malnutrition. These statistics are of major concern because markers of protein-energy malnutrition are strong predictors of morbidity and mortality. The causes of protein-energy malnutrition in patients with chronic renal failure include: (1) decreased energy or protein intake; (2) concurrent chronic illnesses, and superimposed acute illnesses and possibly increased inflammatory cytokines; (3) the catabolic stimulus of hemodialysis; (4) losses of nutrients into dialysate, particularly amino acids, peptides, protein (with peritoneal dialysis), glucose (when hemodialysis is performed with glucose-free dialysate) and water-soluble vitamins; and (5) diagnostic or therapeutic (e.g., prednisone therapy) procedures that reduce nutrient intake or engender net protein breakdown. Other theoretically possible causes for protein-energy malnutrition include (6) chronic blood loss; (7) endocrine disorders (especially resistance to insulin and insulin-like growth factor-I, hyperglucagonemia, hyperparathyroidism and deficiency of 1,25-dihydroxycholecalciferol); (8) products of metabolism that accumulate in renal failure and may induce wasting, such as organic and inorganic acids; (9) loss of the metabolic actions of the kidney; and (10) the accumulation of toxic compounds that are taken up from the environment (e.g., aluminum).
引用
收藏
页码:247S / 251S
页数:5
相关论文
共 47 条
[1]   CHRONIC METABOLIC-ACIDOSIS DECREASES ALBUMIN SYNTHESIS AND INDUCES NEGATIVE NITROGEN-BALANCE IN HUMANS [J].
BALLMER, PE ;
MCNURLAN, MA ;
HULTER, HN ;
ANDERSON, SE ;
GARLICK, PJ ;
KRAPF, R .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) :39-45
[2]   CORRELATION BETWEEN INCREASED SERUM AND TISSUE L-CARNITINE LEVELS AND IMPROVED MUSCLE SYMPTOMS IN HEMODIALYZED PATIENTS [J].
BELLINGHIERI, G ;
SAVICA, V ;
MALLAMACE, A ;
DISTEFANO, C ;
CONSOLO, F ;
SPAGNOLI, LG ;
VILLASCHI, S ;
PALMIERI, G ;
CORSI, M ;
MACCARI, F .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1983, 38 (04) :523-531
[3]  
BERGSTROM J, 1994, J AM SOC NEPHROL, V5, P488
[4]  
BERGSTROM J, 1997, NUTR MANAGEMENT RENA, P97
[5]   25-HYDROXYCHOLECALCIFEROL STIMULATION OF MUSCLE METABOLISM [J].
BIRGE, SJ ;
HADDAD, JG .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (05) :1100-1107
[6]   PROTEIN LOSSES DURING PERITONEAL-DIALYSIS [J].
BLUMENKRANTZ, MJ ;
GAHL, GM ;
KOPPLE, JD ;
KAMDAR, AV ;
JONES, MR ;
KESSEL, M ;
COBURN, JW .
KIDNEY INTERNATIONAL, 1981, 19 (04) :593-602
[7]  
BOLOGA RM, 1995, J AM SOC NEPHROL, V6, P573
[8]   1,25 DIHYDROXY-VITAMIN-D3 IN NORMAL MAN AND PATIENTS WITH RENAL-FAILURE [J].
BRICKMAN, AS ;
COBURN, JW ;
MASSRY, SG ;
NORMAN, AW .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :161-168
[9]   EFFECT OF INTRADIALYTIC PARENTERAL-NUTRITION ON MORTALITY-RATES IN END-STAGE RENAL-DISEASE CARE [J].
CAPELLI, JP ;
KUSHNER, H ;
CAMISCIOLI, TC ;
CHEN, SM ;
TORRES, MA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (06) :808-816
[10]  
Chazot C., 2013, NUTR MANAGEMENT RENA, P415, DOI 10.1016/B978-0-12]-391934-2.00024-2